{
    "indexed": {
        "date-parts": [
            [
                2024,
                8,
                11
            ]
        ],
        "date-time": "2024-08-11T23:08:30Z",
        "timestamp": 1723417710605
    },
    "reference-count": 59,
    "publisher": "American Association for Cancer Research (AACR)",
    "issue": "2",
    "funder": [
        {
            "name": "Cell and Molecular Biology Training Program",
            "award": [
                "T32 GM 008056"
            ]
        },
        {
            "name": "Molecular Therapeutics Training Program",
            "award": [
                "T32 GM 008803"
            ]
        }
    ],
    "content-domain": {
        "domain": [
            "aacrjournals.org"
        ],
        "crossmark-restriction": true
    },
    "published-print": {
        "date-parts": [
            [
                2021,
                2,
                1
            ]
        ]
    },
    "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Castration-resistant prostate cancer can be treated with the antiandrogen enzalutamide, but responses and duration of response are variable. To identify genes that support enzalutamide resistance, we performed a short hairpin RNA (shRNA) screen in the bone-homing, castration-resistant prostate cancer cell line, C4-2B. We identified 11 genes (TFAP2C, CAD, SPDEF, EIF6, GABRG2, CDC37, PSMD12, COL5A2, AR, MAP3K11, and ACAT1) whose loss resulted in decreased cell survival in response to enzalutamide. To validate our screen, we performed transient knockdowns in C4-2B and 22Rv1 cells and evaluated cell survival in response to enzalutamide. Through these studies, we validated three genes (ACAT1, MAP3K11, and PSMD12) as supporters of enzalutamide resistance in vitro. Although ACAT1 expression is lower in metastatic castration-resistant prostate cancer samples versus primary prostate cancer samples, knockdown of ACAT1 was sufficient to reduce cell survival in C4-2B and 22Rv1 cells. MAP3K11 expression increases with Gleason grade, and the highest expression is observed in metastatic castration-resistant disease. Knockdown of MAP3K11 reduced cell survival, and pharmacologic inhibition of MAP3K11 with CEP-1347 in combination with enzalutamide resulted in a dramatic increase in cell death. This was associated with decreased phosphorylation of AR-Serine650, which is required for maximal AR activation. Finally, although PSMD12 expression did not change during disease progression, knockdown of PSMD12 resulted in decreased AR and AR splice variant expression, likely contributing to the C4-2B and 22Rv1 decrease in cell survival. Our study has therefore identified at least three new supporters of enzalutamide resistance in castration-resistant prostate cancer cells in vitro.</jats:p>",
    "DOI": "10.1158/1535-7163.mct-20-0244",
    "type": "journal-article",
    "created": {
        "date-parts": [
            [
                2020,
                12,
                9
            ]
        ],
        "date-time": "2020-12-09T17:46:33Z",
        "timestamp": 1607535993000
    },
    "page": "398-409",
    "update-policy": "http://dx.doi.org/10.1158/crossmark_policy",
    "source": "Crossref",
    "is-referenced-by-count": 14,
    "title": [
        "Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells <i>In Vitro</i>"
    ],
    "prefix": "10.1158",
    "volume": "20",
    "author": [
        {
            "ORCID": "http://orcid.org/0000-0002-9754-8894",
            "authenticated-orcid": false,
            "given": "Sarah E.",
            "family": "Kohrt",
            "sequence": "first",
            "affiliation": [
                {
                    "name": "1Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio."
                }
            ]
        },
        {
            "given": "Wisam N.",
            "family": "Awadallah",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "3Department of Urology, Case Western Reserve University, Cleveland, Ohio."
                }
            ]
        },
        {
            "suffix": "III",
            "given": "Robert A.",
            "family": "Phillips",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "4Biological Sciences, Salisbury University, Salisbury, Maryland."
                }
            ]
        },
        {
            "given": "Thomas C.",
            "family": "Case",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "5Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee."
                }
            ]
        },
        {
            "given": "Renjie",
            "family": "Jin",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "5Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee."
                }
            ]
        },
        {
            "given": "Jagpreet S.",
            "family": "Nanda",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "3Department of Urology, Case Western Reserve University, Cleveland, Ohio."
                }
            ]
        },
        {
            "given": "Xiuping",
            "family": "Yu",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "6Department of Biochemistry, Louisiana State University Health Shreveport, Shreveport, Louisiana."
                }
            ]
        },
        {
            "given": "Peter E.",
            "family": "Clark",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "7Department of Urology, Levine Cancer Center/Atrium Health, Charlotte, North Carolina."
                }
            ]
        },
        {
            "given": "Yajun",
            "family": "Yi",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "8Quality, Safety and Risk Prevention, Vanderbilt University Medical Center, Nashville, Tennessee."
                }
            ]
        },
        {
            "given": "Robert J.",
            "family": "Matusik",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "5Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee."
                }
            ]
        },
        {
            "given": "Philip D.",
            "family": "Anderson",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "4Biological Sciences, Salisbury University, Salisbury, Maryland."
                }
            ]
        },
        {
            "ORCID": "http://orcid.org/0000-0003-1550-4925",
            "authenticated-orcid": false,
            "given": "Magdalena M.",
            "family": "Grabowska",
            "sequence": "additional",
            "affiliation": [
                {
                    "name": "1Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "3Department of Urology, Case Western Reserve University, Cleveland, Ohio."
                },
                {
                    "name": "9Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio."
                }
            ]
        }
    ],
    "member": "1086",
    "published-online": {
        "date-parts": [
            [
                2021,
                2,
                5
            ]
        ]
    },
    "reference": [
        {
            "key": "2022060802185239100_bib1",
            "doi-asserted-by": "crossref",
            "first-page": "438",
            "DOI": "10.1111/j.1464-410X.2009.08695.x",
            "article-title": "Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways",
            "volume": "104",
            "author": "Vis",
            "year": "2009",
            "journal-title": "BJU Int"
        },
        {
            "key": "2022060802185239100_bib2",
            "doi-asserted-by": "crossref",
            "first-page": "1437",
            "DOI": "10.1016/S0140-6736(10)60172-9",
            "article-title": "Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1\u20132 study",
            "volume": "375",
            "author": "Scher",
            "year": "2010",
            "journal-title": "Lancet"
        },
        {
            "key": "2022060802185239100_bib3",
            "doi-asserted-by": "crossref",
            "first-page": "983",
            "DOI": "10.1016/S1470-2045(12)70379-0",
            "article-title": "Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study",
            "volume": "13",
            "author": "Fizazi",
            "year": "2012",
            "journal-title": "Lancet Oncol"
        },
        {
            "key": "2022060802185239100_bib4",
            "doi-asserted-by": "crossref",
            "first-page": "1187",
            "DOI": "10.1056/NEJMoa1207506",
            "article-title": "Increased survival with enzalutamide in prostate cancer after chemotherapy",
            "volume": "367",
            "author": "Scher",
            "year": "2012",
            "journal-title": "N Engl J Med"
        },
        {
            "key": "2022060802185239100_bib5",
            "doi-asserted-by": "crossref",
            "first-page": "424",
            "DOI": "10.1056/NEJMoa1405095",
            "article-title": "Enzalutamide in metastatic prostate cancer before chemotherapy",
            "volume": "371",
            "author": "Beer",
            "year": "2014",
            "journal-title": "N Engl J Med"
        },
        {
            "key": "2022060802185239100_bib6",
            "first-page": "2577",
            "article-title": "Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer",
            "volume": "54",
            "author": "Thalmann",
            "year": "1994",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib7",
            "doi-asserted-by": "crossref",
            "first-page": "3198",
            "DOI": "10.1158/1078-0432.CCR-13-3296",
            "article-title": "Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer",
            "volume": "20",
            "author": "Liu",
            "year": "2014",
            "journal-title": "Clin Cancer Res"
        },
        {
            "key": "2022060802185239100_bib8",
            "author": "Epi Info. Version 7.1.5",
            "year": "2015",
            "journal-title": "Centers for Disease Control and Prevention"
        },
        {
            "key": "2022060802185239100_bib9",
            "doi-asserted-by": "crossref",
            "first-page": "139",
            "DOI": "10.1093/bioinformatics/btp616",
            "article-title": "edgeR: a bioconductor package for differential expression analysis of digital gene expression data",
            "volume": "26",
            "author": "Robinson",
            "year": "2010",
            "journal-title": "Bioinformatics"
        },
        {
            "key": "2022060802185239100_bib10",
            "article-title": "edgeR: empirical analysis of digital gene expression data in R",
            "author": "Chen",
            "year": "2016"
        },
        {
            "key": "2022060802185239100_bib11",
            "doi-asserted-by": "crossref",
            "article-title": "limma: linear models for microarray data",
            "author": "Smyth",
            "year": "2005",
            "DOI": "10.1007/0-387-29362-0_23"
        },
        {
            "key": "2022060802185239100_bib12",
            "article-title": "limma: linear models for microarray data",
            "author": "Smyth",
            "year": "2016"
        },
        {
            "key": "2022060802185239100_bib13",
            "doi-asserted-by": "crossref",
            "first-page": "4948",
            "DOI": "10.1158/0008-5472.CAN-16-0902",
            "article-title": "Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome",
            "volume": "76",
            "author": "You",
            "year": "2016",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib14",
            "doi-asserted-by": "crossref",
            "first-page": "pl1",
            "DOI": "10.1126/scisignal.2004088",
            "article-title": "Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal",
            "volume": "6",
            "author": "Gao",
            "year": "2013",
            "journal-title": "Sci Signal"
        },
        {
            "key": "2022060802185239100_bib15",
            "doi-asserted-by": "crossref",
            "first-page": "401",
            "DOI": "10.1158/2159-8290.CD-12-0095",
            "article-title": "The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data",
            "volume": "2",
            "author": "Cerami",
            "year": "2012",
            "journal-title": "Cancer Discov"
        },
        {
            "key": "2022060802185239100_bib16",
            "doi-asserted-by": "crossref",
            "first-page": "11428",
            "DOI": "10.1073/pnas.1902651116",
            "article-title": "Genomic correlates of clinical outcome in advanced prostate cancer",
            "volume": "116",
            "author": "Abida",
            "year": "2019",
            "journal-title": "Proc Natl Acad Sci U S A"
        },
        {
            "key": "2022060802185239100_bib17",
            "author": "Analysis of metastatic prostate adenocarcinoma (SU2C/PCF Dream Team, PNAS 2019)"
        },
        {
            "key": "2022060802185239100_bib18",
            "doi-asserted-by": "crossref",
            "first-page": "26259",
            "DOI": "10.18632/oncotarget.8456",
            "article-title": "Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer",
            "volume": "7",
            "author": "Kregel",
            "year": "2016",
            "journal-title": "Oncotarget"
        },
        {
            "key": "2022060802185239100_bib19",
            "doi-asserted-by": "crossref",
            "first-page": "1058",
            "DOI": "10.1002/pros.24019",
            "article-title": "Increased nuclear factor I/B expression in prostate cancer correlates with AR expression",
            "volume": "80",
            "author": "Nanda",
            "year": "2020",
            "journal-title": "Prostate"
        },
        {
            "key": "2022060802185239100_bib20",
            "doi-asserted-by": "crossref",
            "first-page": "134",
            "DOI": "10.1186/1471-2105-13-134",
            "article-title": "Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction",
            "volume": "13",
            "author": "Ye",
            "year": "2012",
            "journal-title": "BMC Bioinformatics"
        },
        {
            "key": "2022060802185239100_bib21",
            "doi-asserted-by": "crossref",
            "first-page": "1710",
            "DOI": "10.1158/1541-7786.MCR-18-1233",
            "article-title": "Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer",
            "volume": "17",
            "author": "Dahl",
            "year": "2019",
            "journal-title": "Mol Cancer Res"
        },
        {
            "key": "2022060802185239100_bib22",
            "doi-asserted-by": "crossref",
            "first-page": "5228",
            "DOI": "10.1158/0008-5472.CAN-17-0320",
            "article-title": "Targeting a single alternative polyadenylation site coordinately blocks expression of androgen receptor mRNA splice variants in prostate cancer",
            "volume": "77",
            "author": "Van Etten",
            "year": "2017",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib23",
            "doi-asserted-by": "crossref",
            "first-page": "483",
            "DOI": "10.1158/0008-5472.CAN-12-3630",
            "article-title": "Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines",
            "volume": "73",
            "author": "Li",
            "year": "2013",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib24",
            "doi-asserted-by": "crossref",
            "first-page": "11890",
            "DOI": "10.1073/pnas.182376299",
            "article-title": "The program of androgen-responsive genes in neoplastic prostate epithelium",
            "volume": "99",
            "author": "Nelson",
            "year": "2002",
            "journal-title": "Proc Natl Acad Sci U S A"
        },
        {
            "key": "2022060802185239100_bib25",
            "doi-asserted-by": "crossref",
            "first-page": "10104",
            "DOI": "10.1093/nar/gkz790",
            "article-title": "Molecular determinants for enzalutamide-induced transcription in prostate cancer",
            "volume": "47",
            "author": "Yuan",
            "year": "2019",
            "journal-title": "Nucleic Acids Res"
        },
        {
            "key": "2022060802185239100_bib26",
            "doi-asserted-by": "crossref",
            "first-page": "3971",
            "DOI": "10.1007/s00018-011-0766-7",
            "article-title": "Androgen receptor and its splice variants in prostate cancer",
            "volume": "68",
            "author": "Haile",
            "year": "2011",
            "journal-title": "Cell Mol Life Sci"
        },
        {
            "key": "2022060802185239100_bib27",
            "doi-asserted-by": "crossref",
            "first-page": "372",
            "DOI": "10.1002/pros.22758",
            "article-title": "Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression",
            "volume": "74",
            "author": "Saraon",
            "year": "2014",
            "journal-title": "Prostate"
        },
        {
            "key": "2022060802185239100_bib28",
            "doi-asserted-by": "crossref",
            "first-page": "1589",
            "DOI": "10.1074/mcp.M112.023887",
            "article-title": "Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression",
            "volume": "12",
            "author": "Saraon",
            "year": "2013",
            "journal-title": "Mol Cell Proteomics"
        },
        {
            "key": "2022060802185239100_bib29",
            "doi-asserted-by": "crossref",
            "first-page": "e38950",
            "DOI": "10.1371/journal.pone.0038950",
            "article-title": "Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen",
            "volume": "7",
            "author": "Whitworth",
            "year": "2012",
            "journal-title": "PLoS One"
        },
        {
            "key": "2022060802185239100_bib30",
            "first-page": "605",
            "article-title": "Identification of three proline-directed phosphorylation sites in the human androgen receptor",
            "volume": "9",
            "author": "Wilson",
            "year": "1995",
            "journal-title": "Mol Endocrinol"
        },
        {
            "key": "2022060802185239100_bib31",
            "doi-asserted-by": "crossref",
            "first-page": "86",
            "DOI": "10.1016/j.brainres.2003.11.073",
            "article-title": "Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells",
            "volume": "1003",
            "author": "Mathiasen",
            "year": "2004",
            "journal-title": "Brain Res"
        },
        {
            "key": "2022060802185239100_bib32",
            "doi-asserted-by": "crossref",
            "first-page": "25302",
            "DOI": "10.1074/jbc.M011601200",
            "article-title": "CEP-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family",
            "volume": "276",
            "author": "Maroney",
            "year": "2001",
            "journal-title": "J Biol Chem"
        },
        {
            "key": "2022060802185239100_bib33",
            "first-page": "421",
            "article-title": "CEP-1347/KT-7515, an Inhibitor of c-jun N-terminal kinase activation, attenuates the 1-Methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo",
            "volume": "288",
            "author": "Saporito",
            "year": "1999",
            "journal-title": "J Pharmacol Exp Ther"
        },
        {
            "key": "2022060802185239100_bib34",
            "doi-asserted-by": "crossref",
            "first-page": "1",
            "DOI": "10.1200/PO.17.00140",
            "article-title": "Genomic resistance patterns to second-generation androgen blockade in paired tumor biopsies of metastatic castration-resistant prostate cancer",
            "author": "Han",
            "year": "2017",
            "journal-title": "JCO Precision Oncology"
        },
        {
            "key": "2022060802185239100_bib35",
            "doi-asserted-by": "crossref",
            "first-page": "1028",
            "DOI": "10.1056/NEJMoa1315815",
            "article-title": "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer",
            "volume": "371",
            "author": "Antonarakis",
            "year": "2014",
            "journal-title": "N Engl J Med"
        },
        {
            "key": "2022060802185239100_bib36",
            "doi-asserted-by": "crossref",
            "first-page": "e27861",
            "DOI": "10.7554/eLife.27861",
            "article-title": "Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer",
            "volume": "6",
            "author": "Shah",
            "year": "2017",
            "journal-title": "Elife."
        },
        {
            "key": "2022060802185239100_bib37",
            "doi-asserted-by": "crossref",
            "first-page": "40690",
            "DOI": "10.18632/oncotarget.9816",
            "article-title": "Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor",
            "volume": "7",
            "author": "Coleman",
            "year": "2016",
            "journal-title": "Oncotarget"
        },
        {
            "key": "2022060802185239100_bib38",
            "doi-asserted-by": "crossref",
            "first-page": "802",
            "DOI": "10.1016/j.neo.2019.06.002",
            "article-title": "Circulating tumor cell-based molecular classifier for predicting resistance to abiraterone and enzalutamide in metastatic castration-resistant prostate cancer",
            "volume": "21",
            "author": "Chung",
            "year": "2019",
            "journal-title": "Neoplasia"
        },
        {
            "key": "2022060802185239100_bib39",
            "doi-asserted-by": "crossref",
            "first-page": "584",
            "DOI": "10.1016/j.ccell.2020.03.001",
            "article-title": "Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation",
            "volume": "37",
            "author": "Zhang",
            "year": "2020",
            "journal-title": "Cancer Cell"
        },
        {
            "key": "2022060802185239100_bib40",
            "doi-asserted-by": "crossref",
            "first-page": "289",
            "DOI": "10.1016/j.ymgme.2006.07.010",
            "article-title": "Inborn errors of isoleucine degradation: a review",
            "volume": "89",
            "author": "Korman",
            "year": "2006",
            "journal-title": "Mol Genet Metab"
        },
        {
            "key": "2022060802185239100_bib41",
            "doi-asserted-by": "crossref",
            "first-page": "859",
            "DOI": "10.1016/j.molcel.2016.10.014",
            "article-title": "Tetrameric acetyl-CoA acetyltransferase 1 is important for tumor growth",
            "volume": "64",
            "author": "Fan",
            "year": "2016",
            "journal-title": "Mol Cell"
        },
        {
            "key": "2022060802185239100_bib42",
            "doi-asserted-by": "crossref",
            "first-page": "71417",
            "DOI": "10.18632/oncotarget.12163",
            "article-title": "Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis",
            "volume": "7",
            "author": "DePaolo",
            "year": "2016",
            "journal-title": "Oncotarget"
        },
        {
            "key": "2022060802185239100_bib43",
            "doi-asserted-by": "crossref",
            "first-page": "14833",
            "DOI": "10.3390/ijms140714833",
            "article-title": "Posttranslational modification of the androgen receptor in prostate cancer",
            "volume": "14",
            "author": "van der Steen",
            "year": "2013",
            "journal-title": "Int J Mol Sci"
        },
        {
            "key": "2022060802185239100_bib44",
            "doi-asserted-by": "crossref",
            "first-page": "8563",
            "DOI": "10.1128/MCB.23.23.8563-8575.2003",
            "article-title": "Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth",
            "volume": "23",
            "author": "Fu",
            "year": "2003",
            "journal-title": "Mol Cell Biol"
        },
        {
            "key": "2022060802185239100_bib45",
            "doi-asserted-by": "crossref",
            "first-page": "245",
            "DOI": "10.1016/0090-6980(92)90017-N",
            "article-title": "Sulfasalazine inhibits lyso-PAF: Acetyl-CoA acetyltransferase",
            "volume": "44",
            "author": "Faison",
            "year": "1992",
            "journal-title": "Prostaglandins"
        },
        {
            "key": "2022060802185239100_bib46",
            "doi-asserted-by": "crossref",
            "first-page": "15092",
            "DOI": "10.1016/S0021-9258(17)36578-X",
            "article-title": "Identification and characterization of SPRK, a novel src-homology 3 domain-containing proline-rich kinase with serine/threonine kinase activity",
            "volume": "269",
            "author": "Gallo",
            "year": "1994",
            "journal-title": "J Biol Chem"
        },
        {
            "key": "2022060802185239100_bib47",
            "doi-asserted-by": "crossref",
            "first-page": "51",
            "DOI": "10.3390/cancers8050051",
            "article-title": "MLK3 signaling in cancer invasion",
            "volume": "8",
            "author": "Rattanasinchai",
            "year": "2016",
            "journal-title": "Cancers"
        },
        {
            "key": "2022060802185239100_bib48",
            "doi-asserted-by": "crossref",
            "first-page": "503",
            "DOI": "10.1210/me.2005-0351",
            "article-title": "Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization",
            "volume": "20",
            "author": "Gioeli",
            "year": "2006",
            "journal-title": "Mol Endocrinol"
        },
        {
            "key": "2022060802185239100_bib49",
            "doi-asserted-by": "crossref",
            "first-page": "1480",
            "DOI": "10.1212/01.wnl.0000277648.63931.c0",
            "article-title": "Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease",
            "volume": "69",
            "author": "Parkinson Study Group PRECEPT Investigators",
            "year": "2007",
            "journal-title": "Neurology"
        },
        {
            "key": "2022060802185239100_bib50",
            "doi-asserted-by": "crossref",
            "first-page": "8032",
            "DOI": "10.1021/jm401094t",
            "article-title": "Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3",
            "volume": "56",
            "author": "Goodfellow",
            "year": "2013",
            "journal-title": "J Med Chem"
        },
        {
            "key": "2022060802185239100_bib51",
            "doi-asserted-by": "crossref",
            "first-page": "3700",
            "DOI": "10.1038/onc.2014.302",
            "article-title": "Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression",
            "volume": "34",
            "author": "Jin",
            "year": "2014",
            "journal-title": "Oncogene"
        },
        {
            "key": "2022060802185239100_bib52",
            "doi-asserted-by": "crossref",
            "first-page": "3179",
            "DOI": "10.3892/ol.2016.4340",
            "article-title": "Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3",
            "volume": "11",
            "author": "Aras",
            "year": "2016",
            "journal-title": "Oncol Lett"
        },
        {
            "key": "2022060802185239100_bib53",
            "doi-asserted-by": "crossref",
            "first-page": "2763",
            "DOI": "10.1158/0008-5472.CAN-13-2543",
            "article-title": "NF-\u03baB gene signature predicts prostate cancer progression",
            "volume": "74",
            "author": "Jin",
            "year": "2014",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib54",
            "doi-asserted-by": "crossref",
            "first-page": "328",
            "DOI": "10.1038/35002111",
            "article-title": "Regulation of carbamoyl phosphate synthetase by MAP kinase",
            "volume": "403",
            "author": "Graves",
            "year": "2000",
            "journal-title": "Nature"
        },
        {
            "key": "2022060802185239100_bib55",
            "doi-asserted-by": "crossref",
            "first-page": "460",
            "DOI": "10.1096/fj.11-191296",
            "article-title": "Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence",
            "volume": "26",
            "author": "Morin",
            "year": "2011",
            "journal-title": "FASEB J"
        },
        {
            "key": "2022060802185239100_bib56",
            "doi-asserted-by": "crossref",
            "first-page": "11942",
            "DOI": "10.1158/0008-5472.CAN-07-3162",
            "article-title": "Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells",
            "volume": "67",
            "author": "Gray",
            "year": "2007",
            "journal-title": "Cancer Res"
        },
        {
            "key": "2022060802185239100_bib57",
            "doi-asserted-by": "crossref",
            "first-page": "2974",
            "DOI": "10.1200/JCO.19.00799",
            "article-title": "ARCHES: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer",
            "volume": "37",
            "author": "Armstrong",
            "year": "2019",
            "journal-title": "J Clin Oncol"
        },
        {
            "key": "2022060802185239100_bib58",
            "doi-asserted-by": "crossref",
            "first-page": "1094",
            "DOI": "10.1210/en.2015-1312",
            "article-title": "Nfib regulates transcriptional networks that control the development of prostatic hyperplasia",
            "volume": "157",
            "author": "Grabowska",
            "year": "2016",
            "journal-title": "Endocrinology"
        },
        {
            "key": "2022060802185239100_bib59",
            "doi-asserted-by": "crossref",
            "first-page": "949",
            "DOI": "10.1210/me.2013-1213",
            "article-title": "NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression",
            "volume": "28",
            "author": "Grabowska",
            "year": "2014",
            "journal-title": "Mol Endocrinol"
        }
    ],
    "container-title": [
        "Molecular Cancer Therapeutics"
    ],
    "language": "en",
    "link": [
        {
            "URL": "https://aacrjournals.org/mct/article-pdf/20/2/398/1868557/398.pdf",
            "content-type": "application/pdf",
            "content-version": "vor",
            "intended-application": "syndication"
        },
        {
            "URL": "https://aacrjournals.org/mct/article-pdf/20/2/398/1868557/398.pdf",
            "content-type": "unspecified",
            "content-version": "vor",
            "intended-application": "similarity-checking"
        }
    ],
    "deposited": {
        "date-parts": [
            [
                2022,
                6,
                8
            ]
        ],
        "date-time": "2022-06-08T03:56:00Z",
        "timestamp": 1654660560000
    },
    "score": 12.0676565,
    "resource": {
        "primary": {
            "URL": "https://aacrjournals.org/mct/article/20/2/398/93268/Identification-of-Genes-Required-for-Enzalutamide"
        }
    },
    "issued": {
        "date-parts": [
            [
                2021,
                2,
                1
            ]
        ]
    },
    "references-count": 59,
    "journal-issue": {
        "issue": "2",
        "published-online": {
            "date-parts": [
                [
                    2021,
                    2,
                    5
                ]
            ]
        },
        "published-print": {
            "date-parts": [
                [
                    2021,
                    2,
                    1
                ]
            ]
        }
    },
    "URL": "http://dx.doi.org/10.1158/1535-7163.mct-20-0244",
    "relation": {
        "has-preprint": [
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.22521630",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.22521636",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.c.6543087.v1",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.22521630.v1",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.c.6543087",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1101/2020.03.27.011825",
                "asserted-by": "object"
            },
            {
                "id-type": "doi",
                "id": "10.1158/1535-7163.22521636.v1",
                "asserted-by": "object"
            }
        ]
    },
    "ISSN": [
        "1535-7163",
        "1538-8514"
    ],
    "issn-type": [
        {
            "value": "1535-7163",
            "type": "print"
        },
        {
            "value": "1538-8514",
            "type": "electronic"
        }
    ],
    "published": {
        "date-parts": [
            [
                2021,
                2,
                1
            ]
        ]
    }
}